FreeIn Brief J&J Innovation and Boston University form lung cancer research alliance June 08, 2018Vol.44 No.23
Free Sharpless: NCI adds $10 million for NCTN and NCORP trials June 08, 2018Vol.44 No.23By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Abrams: Only about 20-30 percent of the group might benefit from chemotherapy June 08, 2018Vol.44 No.23By Paul Goldberg
Free Big takeaway from ASCO:70 percent of women with early breast cancer don't benefit from adjuvant chemotherapy June 08, 2018Vol.44 No.23By Paul Goldberg
Clinical RoundupFree Tecentriq plus chemo helped metastatic non-squamous NSCLC live longer vs. chemo alone June 01, 2018Vol.44 No.22
Clinical RoundupFree Lung cancer risk drops substantially within five years of quitting smoking June 01, 2018Vol.44 No.22
FreeTrials & Tribulations Why process matters: Considering the ACS colon cancer screening guideline June 01, 2018Vol.44 No.22By David Ransohoff
FreeIn Brief Berlin named to new leadership post at Vanderbilt-Ingram Cancer Center June 01, 2018Vol.44 No.22
